Johnson & Johnson ($JNJ) is the latest Big Pharma company that has vowed to open its clinical trial data vaults to the public. Going a step further than previous efforts, it’s enlisting the help of Yale University to manage data requests.
Under an agreement with the Yale School of Medicine, the school’s Open Data Access (YODA) Project will serve as an independent body to oversee requests from investigators and physicians looking to access anonymized clinical trial data from J&J’s Janssen. YODA, not J&J, will review each request and make final decisions on data sharing. Members of the YODA team will select and appoint an independent external panel of non-Janssen experts to help in some cases to assess requests.
{iframe}http://www.fiercebiotech.com/story/jj-enlists-yale-oversee-clinical-trials-data-sharing/2014-01-30?utm_medium=nl&utm_source=internal{/iframe}